PROPERTY, PLANT AND EQUIPMENT, NET (Details Narrative) - Maius Pharmaceutical Co. Ltd [Member] - USD ($) |
6 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| Restructuring Cost and Reserve [Line Items] | ||||
| Depreciation | $ 489 | $ 1,112 | $ 2,119 | $ 2,304 |
| Impairment loss for property plant and equipment | $ 0 | $ 0 | $ 0 | $ 0 |
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|